Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.815 USD | -0.39% | +2.55% | -7.85% |
05-08 | Transcript : Relmada Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Relmada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.85% | 116M | |
+3.19% | 108B | |
+10.22% | 105B | |
+1.57% | 23.46B | |
-13.04% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.97% | 17.19B | |
+5.86% | 13.99B | |
+37.09% | 12.53B |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Relmada Says Chief Medical Officer Leaving; Names Senior Clinical Development Advisor